43results about How to "Increase oxygen saturation" patented technology

An electronic endoscope system includes a light source device for sequentially emitting plural kinds of light having different wavelength bands, an electronic endoscope for outputting image data of acquired images corresponding to the plural kinds of light sequentially illuminated to a subject tissue containing blood vessels, a setter for setting a blood vessel characteristics amount from the image data, a setter for setting a region of interest in the acquired image based on the amount, an image producer for producing a first oxygen saturation level image representing a distribution of an oxygen saturation level in the blood vessel from the image data, and an image display for displaying in simulated color a second oxygen saturation level image in which the oxygen saturation level within the region of interest is selectively enhanced.

A versatile, multi-port, intubation-permitting oxygen mask is provided including two diaphragms (nasal and oral) each configured with a continuous, flexible, modifiable membrane from which an instrument-access port may be manually constructed, when and if needed. The novel oxygen mask preferably includes a multiple-inlet port having a standard oxygen tube connector and an interchangeable breathing-therapy device connector, a carbon dioxide sampling port, an exhaust port, and a nose clip. The mask can be worn as a standard oxygen mask during traditional oxygen therapy, yet quickly converted into an intubation mask. The clinician manually perforates the nasal and / or oral diaphragm to create a point and size of entry perfectly matched to the requirements for a variety of procedures that may be performed involving nasally or orally introduced scopes or probes—without disturbing the ongoing benefits of increased oxygen saturation and continuous monitoring of expired gases.

A versatile, intubation-facilitating oxygen mask is provided including at least one diaphragm configured with a continuous, flexible, modifiable membrane from which an instrument-access port may be manually constructed, when and if needed. The novel oxygen mask preferably includes a multiple-inlet port having a standard oxygen tube connector and an interchangeable breathing-therapy device connector, a carbon dioxide sampling port, an exhaust port, and a nose clip. The mask can be worn as a standard oxygen mask during traditional oxygen therapy, yet quickly converted into an intubation mask. The clinician manually perforates the nasal and / or oral membranes of the one or more diaphragms to create a point and size of entry perfectly matched to the requirements for a variety of procedures that may be performed involving nasally or orally introduced scopes or probes—without disturbing the ongoing benefits of increased oxygen saturation and continuous monitoring of expired gases.

A device and a process for controlling a respirator with inclusion of an oxygen saturation value (34) for compensating a device-dependent time response (15), a physiological time response (16) and a measuring method-dependent time response (17) are described. The device-dependent time response (15), the physiological time response (16) and the measuring method-dependent time response (17) are determined in a continuous sequence and a run time of a change in the oxygen concentration from the metering means (9) in the respirator to the patient (4) is determined and taken into account in regulating the oxygen concentration.

The invention discloses a self-foaming cosmetic composition. The self-foaming cosmetic composition is prepared from the ingredients in percentage by mass: 50-99.9% of cosmetic matrix and 0.1-50% of foamer, wherein the foamer is a fluorine containing ether compound, and the cosmetic matrix is prepared from deionized water, alcohols, an aqueous-phase tackifier, a humectant, an anionic surfactant, a zwitterionic surfactant, a non-ionic surfactant, fat and oil, an inorganic salt or macromolecular thickener, an alkaline neutralizing agent, an active ingredient, a preservative and essence. The self-foaming cosmetic composition disclosed by the invention has the advantages that the condition of skin can be obviously improved so as to enable the skin to be tender and bright and smooth wrinkles.

The invention discloses a self-foaming cosmetic composition. The self-foaming cosmetic composition is prepared from the ingredients in percentage by mass: 65-99.5% of cosmetic matrix and 0.5-35% of foamer, wherein the foamer is a fluorine containing ether compound, and the cosmetic matrix is prepared from deionized water, alcohols, an aqueous-phase tackifier, a humectant, an anionic surfactant, a zwitterionic surfactant, a non-ionic surfactant, fat and oil, an inorganic salt or macromolecular thickener, an alkaline neutralizing agent, an active ingredient, a preservative and essence. The self-foaming cosmetic composition disclosed by the invention has the advantages that the condition of skin can be obviously improved so as to enable the skin to be tender and bright and smooth wrinkles.

A versatile, intubation-facilitating oxygen mask is provided including at least one diaphragm configured with a continuous, flexible, modifiable membrane from which an instrument-access port may be manually constructed, when and if needed. The novel oxygen mask preferably includes a multiple-inlet port having a standard oxygen tube connector and an interchangeable breathing-therapy device connector, a carbon dioxide sampling port, an exhaust port, and a nose clip. The mask can be worn as a standard oxygen mask during traditional oxygen therapy, yet quickly converted into an intubation mask. The clinician manually perforates the nasal and / or oral membranes of the one or more diaphragms to create a point and size of entry perfectly matched to the requirements for a variety of procedures that may be performed involving nasally or orally introduced scopes or probes—without disturbing the ongoing benefits of increased oxygen saturation and continuous monitoring of expired gases.

The invention relates to the combined administration of a PDE4 inhibitor and a PDE5 inhibitor for the treatment of a disease in which phosphodiesterase 4 (PDE4) and / or phosphodiesterase 5 (PDE5) is detrimental.

The present invention provides a method for determining at least one evaluation parameter of a blood sample, comprising the following steps: providing (S4) at least one blood gas parameter; providing (S5) at least one hemostasis parameter; and determining (S6 . . . S10″) the at least one evaluation parameter as a function of the blood gas parameter and / or the hemostasis parameter.

Formulations of human amniotic fluid and methods of use thereof for treatment of lung disorders, and / or injuries have been developed. The formulations are suitable for topical delivery to the lung for treatment of lung disorders including chronic obstructive pulmonary disorders (COPD), asthma, emphysema, bronchiectasis, chronic bronchitis, interstitial lung disease, alpha-1 antitrypsin emphysema, as well as for treatment of acute lung injuries. Methods including administering specifically formulated, diluted sterile de-cellularized human amniotic fluids topically to the lungs, preferably as aerosol droplets, are described. In particular, the methods involving administration of the amniotic fluid formulation in the form of aerosol droplets with size between about 1.5 μm to about 5 μm, preferably from about 2.5 μm to about 3.5 μm, inclusive, using apparatus such as high-efficiency vibrating mesh nebulizers, are described. Formulations described can treat, or prevent one or more symptoms of a chronic lung disorder.

A sleep apnoea treatment device comprises a mouthpiece including a vestibular locator and an airway conduit. The vestibular locator is adapted for positioning in the mouth vestibule of a user interposed between the lips and teeth of the user. The vestibular locator is to support the airway conduit in place relative to the user's mouth with the airway conduit extending between the lips of the user whereby the airway conduit maintains fluid communication of the mouth vestibule with ambient air to facilitate the user breathing ambient air through the airway conduit.

Methods of treating pulmonary sarcoidosis are described herein. Patients in need of treatment for pulmonary sarcoidosis are administered a therapeutically effective amount of a mucolytic agent such as DNase I. In some embodiments, the DNase I is a recombinant human DNase I such as dornase alfa.

The present invention has shown that not all salts of pyruvic acid enhance lung functions or enhance the synthesis of lung surfactants and that certain salts of pyruvic acid with the correct concentrations of calcium, phosphate and magnesium, is are synergistic in their ability to enhance the synthesis of lung surfactants that will enhance lung alveoli functions, while decreasing coughing and lung tightness, and increasing oxygen saturation values to prevent hypoxemia. This patent demonstrates that the sodium pyruvate formula with calcium, phosphate and magnesium was superior over standard sodium pyruvate formula in saline alone in the removal of mucus, reduction of lung or sinus infections, and in reducing drug side effects and congestion. The use of this formula clearly demonstrated that it can be used to produce better efficacy in patients with hypoxemia, with lung and sinus diseases including, asthma, COPD, cystic fibrosis, interstitial lung disease, allergic rhinitis, sinusitis, Alzheimer's, disease, Parkinson's disease, brain trauma, nicotine addiction, sleep apnea, autism, migraine headaches, sleep disorders, lung and sinus infections, cancer therapy with cancer drugs, nicotine addiction, and medications that cause a decrease in lung surfactants.

Formulations of human amniotic fluid and methods of use thereof for treatment of lung disorders, and / or injuries have been developed. The formulations are suitable for topical delivery to the lung for treatment of lung disorders including chronic obstructive pulmonary disorders (COPD), asthma, emphysema, bronchiectasis, chronic bronchitis, interstitial lung disease, alpha-1 antitrypsin emphysema, as well as for treatment of acute lung injuries. Methods including administering specifically formulated, diluted sterile de-cellularized human amniotic fluids topically to the lungs, preferably as aerosol droplets, are described. In particular, the methods involving administration of the amniotic fluid formulation in the form of aerosol droplets with size between about 1.5 μm to about 5 μm, preferably from about 2.5 μm to about 3.5 μm, inclusive, using apparatus such as high-efficiency vibrating mesh nebulizers, are described. Formulations described can treat, or prevent one or more symptoms of a chronic lung disorder.

The invention relates to the combined administration of a PDE4 inhibitor and a PDE5 inhibitor for the treatment of a disease in which phosphodiesterase 4 (PDE4) and / or phosphodiesterase 5 (PDE5) is detrimental.

The invention discloses a purifying and oxygen filling device for processing high-density aquatic water by water aerosol and relates to the aquaculture industry. The purifying and oxygen filling device comprises a water aerosol generator, a water pump, a jet pipe, a water absorption tube, a conveying pipe and a distributor. The purifying and oxygen filling device is characterized in that a water source in a culture pond is pumped by the water pump and is input into the water aerosol generator, a great amount of microbubbles are mixed into the water aerosol, and the water aerosol is slowly and uniformly distributed at the bottom of the culture pond after being depressurized. By utilizing the adsorption characteristic of a great amount of microbubbles in the water aerosol, low-gravity suspended matters in the water are adsorbed and collected to ascend and high-gravity suspended matters in the water are adsorbed and collected to be sunk, so that the low-gravity suspended matters and the high-gravity suspended matters are convenient to remove. By utilizing the characteristics of large relative surface are and high solubility of the microbubbles, original gas dissolved in the water is competitively pushed out and replaced and the oxygen saturation of the water is improved. Compared with the prior art, the purifying and oxygen filling device has the advantages of simple structure, easiness for implementation, operation and control, low cost, good effect, slowness and uniformity for inputting the water aerosol, small movement, low noise, low influence and interference on the water and cultured objects and the like, and thus, the purifying and oxygen filling device has high popularization and use value.

The invention relates to an adult simple breathing training balloon and a using method thereof. The training balloon comprises a one-way exhaust valve, a safety valve, a balloon main body and an air inlet valve, wherein the one-way exhaust valve is arranged at one end of the balloon main body, the safety valve is arranged between the one-way exhaust valve and the balloon main body, and the air inlet valve is arranged at the other end of the balloon main body, and the duckbill arranged on the one-way exhaust valve is directly connected with the tracheal cannula of a patient. The adult simple breathing training balloon is directly connected with the tracheal cannula of a patient, by pressing the balloon, the therapist or the nurse can perform the breathing training for the patient with clearconsciousness, and can directly carry out the lung breathing training for patients with unconsciousness by observing the breathing situation of the patient.

The present invention relates to methods for treating obstructive sleep apnea (OSA), alleviating a negative OSA symptom, reducing snoring, or improving quality of life in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising pyridostigmine before sleep. Also provided are related medicaments as well as methods for preparing the medicaments.

The invention relates to an apparatus and a method for the treatment of the blood in a Continuous Renal Replacement Therapy, using a machine which comprises: —connecting means from and to respective blood vessels of a patient; —blood processing means comprising a pump; —means for adding drugs or other therapeutic substances to the blood being treated; —means for feeding refill liquid into the blood; —blood filtration means, cascade-connected to one another by relative conduits, said conduits and said connecting means defining a blood path; wherein the blood to be treated passes through an oxygenating device which comprises an oxygenating membrane and is located upstream from said blood filtration means and downstream from said blood processing means, so that the blood is treated by said oxygenating membrane without the intake pressure along the portion upstream from the blood pump; and wherein the blood is pumped downstream from the connecting means to the oxygenating device at a flow rate of about 280-300 ml / min.

One or more embodiments of the present invention provide a conversion mask that is quick, safe and cost effective and a method for increasing oxygen saturation and / or arresting a subsequent decline in oxygen saturation, which does not unnecessarily increase costs, require a bulky and uncomfortable mask or disrupt the flow of oxygen and / or care being provided to the patient. In one or more embodiments, the conversion mask has a thin, lightweight non latex plastic shield or tent-like mask designed to convert a nasal cannula to a full oxygen capturing mask. The conversion mask serves to capture oxygen escaping from nasal cannula effectively redirecting it back to the mouth and nose, thereby improving oxygenation and / or arresting a decline in oxygenation of patients, particular those under conscious sedation, deep Propofol anesthesia or post general anesthesia, with low oxygen saturation levels until they can be transferred to next level care.

The invention discloses a self-foaming essence, which is composed of deionized water, glycerin, butylene glycol, sodium hyaluronate, betaine, acetyl glucosamine, nicotinamide, xanthan gum, glycerin laurate, lauryl sulfate Ester TEA Salt, Sodium Lauryl Ethyl Ether Succinate Monoester Sulfonate, Hydroxyethyl Acrylate / Sodium Acryloyldimethyl Taurate Copolymer, Sodium Hydroxide, Arbutin, Tocopheryl Acetate, Horse Made of purslane extract, MATRIXYL3000, algae extract, essence, preservative and foaming agent. Wherein, the blowing agent is Novec HFE-7100, PhoenoMulse CE-4 or BB 61. The self-foaming essence of the invention can obviously improve the condition of the skin, make the skin soft and bright, and reduce wrinkles.

The invention discloses a peony renewal mask and a preparation method thereof and relates to the technical field of natural plant cosmetics. The peony renewal mask is prepared from raw materials in parts by weight as follows: 5-10 parts of a peony flower extract, 3-6 parts of a peony root extract, 3-6 parts of a radix notoginseng extract, 3-5 parts of sodium hyaluronate, 2-5 parts of glycerin, 1-3parts of sodium carboxymethyl glucan, 1-3 parts of hydroxyethyl cellulose, 2-3 parts of collagen and 65-75 parts of water. All components in the mask interact with one another, so that the mask can improve metabolism of face skin, promote skin microcirculation, increase skin vitality, whiten and moisturize skin, resist winkles, improve skin brightness and delay skin aging, can moisten skin and has certain effects on chloasma, skin aging, wrinkles and dry and dull skin if often used.

An environment friendly method for culturing the spiny sea cucumber in pond without feeding bait features that the contents of the N in nitrate, ammoniacal nitrogen, the N in nitrite and the soluble phosphate in the seawater in pond are controlled respectively to be 80-120 micrograms / L, 100-400 micrograms / L, 70-100 micrograms / L and 15-25 micrograms / L, and the water depth in pond is less than the transparency of said water.

Methods for the treatment of patients with both Chronic Obstructive Pulmonary Disease (COPD) and pulmonary fibrosis, and of patients with idiopathic pulmonary fibrosis without COPD, by stimulating the synthesis of human and animal patient lung and sinus surfactants to increase lung functions, inhibiting fibrosis and reducing coughing and nasal erythema, include the following steps: A) analyzing and diagnosing a patient with a lung ailment selected from the group consisting of i) both COPD and pulmonary fibrosis; and ii) idiopathic pulmonary fibrosis without COPD; and, B) treating the patient to raise the patient's lung functions including FEV1 / FVC ratio by contacting mammalian cells with a [therapeutically effective amount of a treatment] composition that includes: a) a pyruvate salt; b) a phosphate; c) a salt of calcium; and d) a salt of magnesium, in an aqueous carrier, containing no more than 2.2 grams of said pyruvate salt per liter.

The invention relates to the use of selective agonists of beta-3 adrenergic receptors for the treatment and / or prevention of pulmonary hypertension.

An electronic endoscope system includes a light source device for sequentially emitting plural kinds of light having different wavelength bands, an electronic endoscope for outputting image data of acquired images corresponding to the plural kinds of light sequentially illuminated to a subject tissue containing blood vessels, a setter for setting a blood vessel characteristics amount from the image data, a setter for setting a region of interest in the acquired image based on the amount, an image producer for producing a first oxygen saturation level image representing a distribution of an oxygen saturation level in the blood vessel from the image data, and an image display for displaying in simulated color a second oxygen saturation level image in which the oxygen saturation level within the region of interest is selectively enhanced.

The invention relates to an oropharynx protection and oxygen inhalation combined device for endoscopic minimally invasive diagnosis and treatment. The combined device comprises a seam, an oxygen inhalation nasal mask and an oropharynx protection tube; at least one mushroom-head-shaped fastener is arranged on the extension part of the seam; a connecting hole used for being connected with the fastener is formed in the flange part of the oxygen inhalation nasal mask; the fastener is detachably connected and fixed with the connecting hole; the oropharynx protection tube comprises a flexible cylindrical hollow tube and a connecting tube which are connected with each other, the upper end of the connecting tube is provided with a conical opening allowing an endoscope to enter conveniently, handles are arranged on the two sides of the connecting tube, buckles protruding outwards are arranged on the handles, and the buckles can be inserted into through holes formed in the inner walls of the two sides of a seam body by pressing the handles, so that the connecting tube is connected with the seam body; and an air bag is arranged on the lower portion of the oropharynx protection tube, an interlayer is arranged on the tube wall of the oropharynx protection tube, and an air channel is arranged in the interlayer, communicated with the air bag and communicated with an external air source.

An environment friendly method for culturing the spiny sea cucumber in pond without feeding bait features that the contents of the N in nitrate, ammoniacal nitrogen, the N in nitrite and the soluble phosphate in the seawater in pond are controlled respectively to be 80-120 micrograms / L, 100-400 micrograms / L, 70-100 micrograms / L and 15-25 micrograms / L, and the water depth in pond is less than the transparency of said water.

A soil-less plant cultivation substrate, for use in hydroponic or aeroponic plant cultivation, adapts entangled layers of natural wool batting that has been chemically treated with a compound containing thiol to increase its water holding capacity. In the preferred embodiment, the chemical treatment uses thioglycolic acid, such as calcium thioglycolate or ammonium thioglycolate, to increase the wool's solubility and then a neutralizing agent, such as hydrogen peroxide, halts the process. The thiol compound reduces the disulfide bonds of cysteine in the cortex of the wool and the hydrogen peroxide neutralizes the reaction and oxidizes the cysteines back to cystine, although not all disulfide bonds are reformed. The addition of an alkaline modifier is used to moderate or hasten the breaking the disulfide bonds.

Formulations of human amniotic fluid and methods of use thereof for treatment of lung disorders, and / or injuries have been developed. The formulations are suitable for topical delivery to the lung for treatment of lung disorders including chronic obstructive pulmonary disorders (COPD), asthma, emphysema, bronchiectasis, chronic bronchitis, interstitial lung disease, alpha-1 antitrypsin emphysema, as well as for treatment of acute lung injuries. Methods including administering specifically formulated, diluted sterile de-cellularized human amniotic fluids topically to the lungs, preferably as aerosol droplets, are described. In particular, the methods involving administration of the amniotic fluid formulation in the form of aerosol droplets with size between about 1.5 μm to about 5 μm, preferably from about 2.5 μm to about 3.5 μm, inclusive, using apparatus such as high-efficiency vibrating mesh nebulizers, are described. Formulations described can treat, or prevent one or more symptoms of a chronic lung disorder.